__NUXT_JSONP__("/drugs/MELK_Inhibitor_OTS167", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"An orally available inhibitor of maternal embryonic leucine zipper kinase (MELK) with potential antineoplastic activity. Upon administration, OTS167 binds to MELK, which prevents both MELK phosphorylation and activation; thus inhibiting the phosphorylation of downstream MELK substrates. This may lead to an inhibition of both cell proliferation and survival in MELK-expressing tumor cells. MELK, a serine\u002Fthreonine kinase, is involved in cancer cell survival, invasiveness and cancer-stem cell formation and maintenance; it is highly upregulated in various types of cancer cells and absent in normal, healthy cells.",fdaUniiCode:"VY778IXU5T",identifier:"C111569",preferredName:c,semanticType:"Organic Chemical",subclassOf:["C61074"],synonyms:[c,"OTS-167","OTS167"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FMELK_Inhibitor_OTS167",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","MELK_Inhibitor_OTS167","MELK Inhibitor OTS167","2021-10-30T13:18:19.073Z")));